港股開盤 | 三大指數小幅高開,醫藥股走高
【三大指數】
恆生指數開盤漲49.24點,漲幅0.17%,報28461.50點;
國企指數開盤漲20.47點,漲幅0.19%,報10661.87點;
恆生科技指數開盤漲8.36點,漲幅0.11%,報7884.97點。
【異動板塊】
有色金屬、半導體板塊走高,生物醫藥股亦走強,康希諾生物漲超4%;
教育股受重挫,新東方-S跌超14%。
【異動個股】
快手跌超4%,首季虧損擴大至577.5億元人民幣。
小米漲超2%,被重新納入富時全球股票指數系列。
碧桂園服務跌超1%,擬按每股股份75.25港元(較5月24日收市價80.05港元折讓約6.00%)配售合共1.39億股股份。
滔搏高開6.75%,2020財年營收好於市場預期,淨利潤同比增加近20%。
中國生物製藥高開近5%,第一季度淨利潤接近翻倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.